1 Report Prologue 13
2 Market Introduction 16
2.1 Research Objective 16
2.2 Assumptions & Limitations 17
2.2.1 Assumptions 17
2.2.2 Limitations 17
3 Research Methodology 18
3.1 Research Process 18
3.2 Primary Research 19
3.3 Secondary Research 19
3.4 Market Size Estimation 20
4 Market Dynamics 21
4.1 Introduction 21
4.2 Drivers 22
4.2.1 Growing Prevalence of chronic disorders (Impact weightage: 40%) 22
4.2.2 Growing preference towards minimally invasive surgical procedures (Impact weightage: 35%) 23
4.2.3 Technological Advancements in medical guidewire (Impact weightage: 25%) 24
4.3 Restrains 25
4.3.1 Lack of skilled physicians (impact weightage- 60%) 25
4.3.2 Guide wires associated problems (impact weightage- 40%) 26
4.4 Opportunities 27
4.4.1 Guide wire assisted surgery in elderly population 27
4.4.2 Macroeconomic Indicators 27
5 Market Factor Analysis 29
5.1 Porter's Five Forces Model 29
5.1.1 Bargaining Power of Suppliers 30
5.1.2 Bargaining Power of Buyers 30
5.1.3 Threat of New Entrants 30
5.1.4 Threat of Substitutes 31
5.1.5 Intensity of Rivalry 31
5.2 Value Chain Analysis 31
5.2.1 Raw Material 32
5.2.2 Supplier 33
5.2.3 Manufacturer 34
5.2.4 Distributer 35
5.2.5 Customer 35
5.2.6 Consumer 36
5.3 Demand & Supply: Gap Analysis 37
5.4 Pricing Analysis 37
6 Global Therapeutic Medical Guidewire by Type 38
6.1 Introduction 38
6.2 Solid Guidewire 39
6.3 Wrapped guidewire 40
7 Global Therapeutic Medical guidewire by Shape 41
7.1 Introduction 41
7.2 J-Shape 42
7.3 Angled 43
7.4 Straight 43
8 Global Therapeutic Medical guidewire by Application 44
8.1 Introduction 44
8.2 Peripheral Artery Disease 45
8.3 Cardiovascular Diseases 46
8.4 Neurovascular Diseases 46
8.5 Urological Disease 47
9 Global Therapeutic Medical guidewire by End Users 48
9.1 Introduction 48
9.2 Hospitals 49
9.3 Clinics 50
9.4 Academic Institutes 50
10 Global Therapeutic Medical guidewire by Regions 51
10.1 Introduction 51
10.2 Americas 53
10.2.1 North America 55
10.2.1.1 US 57
10.2.1.2 Canada 58
10.2.2 South America 60
10.3 Europe 62
10.3.1 Western Europe 64
10.3.1.1 Germany 66
10.3.1.2 France 67
10.3.1.3 Italy 69
10.3.1.4 Spain 70
10.3.1.5 UK 72
10.3.1.6 Rest of Western Europe 73
10.3.2 Eastern Europe 75
10.4 Asia Pacific 77
10.4.1 China 79
10.4.2 India 81
10.4.3 Japan 82
10.4.4 South Korea 84
10.4.5 Australia 85
10.4.6 Rest of Asia Pacific 87
10.5 Middle East & Africa 89
10.5.1 UAE 92
10.5.2 Saudi Arabia 93
10.5.3 Oman 95
10.5.4 Kuwait 96
10.5.5 Qatar 98
10.5.6 Rest of Middle East & Africa 99
11 Competitive Landscape 101
11.1 Introduction 101
12 Company Profiles 102
12.1 Cordis (Cardinal Health) 102
12.1.1 Company Overview 102
12.1.2 Financials 102
12.1.3 Products 102
12.1.4 Strategy 102
12.1.5 Key Developments 102
12.2 Biotronik 103
12.2.1 Company Overview 103
12.2.2 Financials 103
12.2.3 Products 103
12.2.4 Strategy 103
12.2.5 Key Developments 103
12.3 SP Medical A S 104
12.3.1 Company Overview 104
12.3.2 Financials 104
12.3.3 Products 104
12.3.4 Strategy 104
12.3.5 Key Developments 104
12.4 Infiniti Medical 105
12.4.1 Company Overview 105
12.4.2 Financials 105
12.4.3 Products 105
12.4.4 Strategy 105
12.4.5 Key Developments 105
12.5 Acme Monaco 106
12.5.1 Company Overview 106
12.5.2 Financials 106
12.5.3 Products 106
12.5.4 Strategy 106
12.5.5 Key Developments 106
12.6 Abbott 107
12.6.1 Company Overview 107
12.6.2 Financials 107
12.6.3 Products 107
12.6.4 Strategy 107
12.6.5 Key Developments 107
12.7 Boston Scientific Corporation 108
12.7.1 Company Overview 108
12.7.2 Financials 108
12.7.3 Products 108
12.7.4 Strategy 108
12.7.5 Key Developments 108
12.8 Medtronic 109
12.8.1 Company Overview 109
12.8.2 Financials 109
12.8.3 Products 109
12.8.4 Strategy 109
12.8.5 Key Developments 109
12.9 Terumo Medical Corporation 110
12.9.1 Company Overview 110
12.9.2 Financials 110
12.9.3 Products 110
12.9.4 Strategy 110
12.9.5 Key Developments 110
12.10 Cook Medical 111
12.10.1 Company Overview 111
12.10.2 Financials 111
12.10.3 Products 111
12.10.4 Strategy 111
12.10.5 Key Developments 111
13 MRFR Conclusion 112
13.1 Key Findings 112
13.1.1 From CEO's View Point 112
13.2 Key Companies to Watch 112
14 Appendix 113
14.1 Discussion Blue Print 113